In Treatment of Abdominal pain Carespas CP 25mg/300mg Tablet effectively relieves sudden muscle spasms or contractions in the stomach and intestine (gut), thereby relaxing the muscles and improving movement of food. It also blocks chemical messengers in the brain that are responsible for pain sensation. This helps to treat abdominal pain (or stomach pain) as well as cramps, bloating and discomfort. Take it as it is prescribed to get the most benefit. Eventually, it will help you to go about your daily activities more easily and have a better, more active, quality of life.
It is unsafe to consume alcohol with Carespas CP 25mg/300mg Tablet.
Information regarding the use of Carespas CP 25mg/300mg Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Carespas CP 25mg/300mg Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Carespas CP 25mg/300mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Carespas CP 25mg/300mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Carespas CP 25mg/300mg Tablet may be needed. Please consult your doctor. However, Carespas CP 25mg/300mg Tablet contains paracetamol which is considered the safest painkiller for kidney disease patients.
Carespas CP 25mg/300mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Carespas CP 25mg/300mg Tablet may be needed. Please consult your doctor. However, the use of Carespas CP 25mg/300mg Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Carespas CP 25mg/300mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Leeford Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ikon Remedies Pvt Ltd || ₹14.5/tablet (25% cheaper)